Psychopharmacological treatment of challenging behaviours in adults with autism and intellectual disabilities: A systematic review

Research in Autism Spectrum Disorders

Volumn 8, Issue 7, 2014, Pages 803-813

  Sawyer, Amanda ^a   Lake, Johanna K ^a   Lunsky, Yona ^a   Liu, Shi Kai ^a   Desarkar, Pushpal ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adults; Autism; Challenging behaviours; Intellectual disability; Psychopharmacology

Indexed keywords

CLOMIPRAMINE; FLUVOXAMINE; RISPERIDONE; SERTRALINE; ZIPRASIDONE;

ADULT DISEASE; AGGRESSION; AUTISM; AUTOMUTILATION; BEHAVIOR DISORDER; COMMUNICATION DISORDER; COMPULSION; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; INTELLECTUAL IMPAIRMENT; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EID: 84899677369     PISSN: 17509467     EISSN: 18780237     Source Type: Journal    
DOI: 10.1016/j.rasd.2014.03.021     Document Type: Review

References (54)

1. R. Alexander, D. Michael, and S. Gangadharan Use of Risperidone in adults with Asperger syndrome British Journal of Developmental Disabilities 50 99 2004 109 115 (Pubitemid 38988448)
2. M.G. Aman, M.E. Van Bourgondien, P.L. Wolford, and G. Sarphare Psychotropic and anticonvulsant drugs in subjects with autism: Prevalence and patterns of use Journal of American Academy of Child and Adolescent Psychiatry 34 1995 1672 1681
3. M.G. Aman, K.L. Lam, and A. Collier-Crespin Prevalence and patterns of psychoactive medicines among individuals with autism in the Autism Society of Ohio Journal of Autism and Developmental Disorders 33 2003 527 534 (Pubitemid 37351601)
4. M.G. Aman, K.S.L. Lam, and M.E. Van Bourgondien Medication patterns in patients with autism: Temporal, regional, and demographic influences Journal of Child and Adolescent Psychopharmacology 15 2005 116 126 (Pubitemid 40365921)
5. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 Sites, United States Surveillance Summary 61 2012 1 19
6. M.J. Bakermans-Kranenburg, and M.H. van Ijzendoorn Sniffing around oxytocin: Review and meta-analysis of trials in health and clinical groups with implications for pharmacotherapy Translational Psychiatry 21 3 2013 10.1038/tp.201334
7. L. Beherec, S. Lambrey, Q. Quilici, A. Rosier, B. Falissard, and O. Guillin Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors Journal of Clinical Psychopharmacology 31 3 2011 341 344
8. E.S. Brodkin, C.J. McDougle, S.T. Naylor, D.J. Cohen, and L.H. Price Clomipramine in adults with pervasive developmental disorders: A prospective open-label investigation Journal of Child and Adolescent Psychopharmacology 7 1997 109 121 (Pubitemid 27421349)
9. J. Brylewski, and L. Duggan Antipsychotic medication for challenging behaviour in people with learning disability Cochrane Database of Systematic Reviews 2004 3
10. S.E. Bryson, E.A. Bradley, A. Thompson, and A. Wainwright Prevalence of autism among adolescents with intellectual disabilities Canadian Journal of Psychiatry 53 2008 449 459
11. H. Ching, and T. Pringsheim Aripiprazole for autism spectrum disorders (ASD) Cochrane Database of Systematic Reviews 16 5 2012 10.1002/14651858. CD009043.pub2
12. S.A. Cohen, B.J. Fitzgerald, S.R.F. Khan, and A. Kahn The effects of a switch to ziprasidone in an adult population with autistic disorder: Chart review of naturalistic, open-label treatment Journal of Clinical Psychiatry 65 2004 110 113
13. T.A. Cohn, and M.J. Sernyak Metabolic monitoring for patients treated with antipsychotic medications Canadian Journal of Psychiatry 5 2006 492 501 (Pubitemid 44166337)
14. S. Deb, and G.L. Unwin Psychotropic medication for behavior problems in people with intellectual disability: A review of the current literature Current Opinion in Psychiatry 20 5 2007 461 466 (Pubitemid 47356749)
15. D. Dove, Z. Warren, M.L. McPheeters, J.L. Taylor, N.A. Sathe, and J. Veenstra-VanderWeele Medications for adolescents and young adults with autism spectrum disorders: A systematic review Pediatrics 130 2012 717 726
16. C.A. Doyle, and C.J. McDougle Pharmacological treatments for the behaviours symptoms associated with autism spectrum disorders across the lifespan Dialogues in Clinical Neuroscience 14 2012 263 279
17. M.G. Edelson Are the majority of children with autism mentally retarded? A systematic evaluation of the data Focus on Autism and Other Developmental Disabilities 21 2006 66 83
18. E. Emerson, and J. Bromley The form and function of challenging behaviours Journal of Intellectual Disability Research 39 5 1995 388 398
19. A.J. Esbensen, J.S. Greenberg, M.M. Seltzer, and M.G. Aman A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders Journal of Autism and Developmental Disorders 39 2009 1339 1349
20. A. Gormez, F. Rana, and S. Varghese Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities Cochrane Database of Systematic Reviews 30 4 2011 10 10.1002/14651858.CD009084.pub2
21. J.E. Graetz Autism grows up: Opportunities for adults with autism Disability and Society 25 2010 33 47
22. A. Hassiotis, C. Parkes, L. Jones, B. Fitzgerald, and R. Romeo Individual characteristics and service expenditure on challenging behaviour for adult with intellectual disabilities Journal of Applied Research in Intellectual Disabilities 21 2008 438 445
23. C.V. Herzinger, and J.M. Campbell Comparing functional assessment methodologies: A quantitative synthesis Journal of Autism and Developmental Disorders 37 2007 1430 1445 (Pubitemid 47255710)
24. J.P. Higgins, D.J. Altman, P.C. Gotzsche, P. Juni, D. Moher, and A.D. Oxman et al. The Cochrane Collaboration's tool for assessing risk of bias in randomized trials British Medical Journal 2011 343 10.1136/bmj.d5928
25. R.H. Homer, E.G. Carr, and P.S. Strain Problem behavior interventions for young children with autism: A research synthesis Journal of Autism and Developmental Disorders 32 2002 423 446 (Pubitemid 37486705)
26. O.S. Jesner, M. Aref-Adib, and E. Coren Risperidone for autism spectrum disorder (review) Cochrane Database of Systematic Reviews 24 1 2007 10.1002/14651858.CD005040.pub2 (Pubitemid 351820566)
27. I. Jordan, D. Robertson, M. Catani, M. Craig, and D. Murphy Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder Psychopharmacology 223 3 2012 357 360
28. G. Kaplan, and J.T. McCracken Psychopharmacology of autism spectrum disorders Pediatric Clinics of North America 59 1 2012 303 314
29. F. Kevan Challenging behaviour and communication difficulties British Journal of Learning Disabilities 31 2003 75 80 (Pubitemid 36766800)
30. J.K. Lake, R. Balogh, and Y. Lunsky Polypharmacy profiles and predictors among adults with autism spectrum disorders Research in Autism Spectrum Disorders 6 2012 1142 1149
31. Y. Lunsky, and J. Elserafi Antipsychotic medication prescription patterns in adults with developmental disabilities who have experienced psychiatric crisis Research in Developmental Disabilities 33 2012 32 38
32. J.L. Matson, and T. Dempsey Autism spectrum disorders: Pharmacotherapy for challenging behaviors Journal of Developmental and Physical Disability 20 2008 175 191
33. J.L. Matson, and T.T. Rivet Characteristics of challenging behaviours in adults with autistic disorder, PDD-NOS, and intellectual disability Journal of Intellectual and Developmental Disabilities 33 2008 323 329
34. J.L. Matson, and M. Shoemaker Intellectual disability and its relationship to autism spectrum disorders Research in Developmental Disabilities 30 2009 1107 1114
35. J.L. Matson, M. Sipes, J.C. Fodstad, and M.E. Fitzgerald Issues in the management of challenging behaviours of adults with autism spectrum disorder CNS Drugs 25 2011 597 606
36. J. McCarthy, C. Hemmings, E. Kravariti, K. Dworzynski, G. Holt, and N. Bouras et al. Challenging behaviour and co-morbid psychopathology in adults with intellectual disability and autism spectrum disorders Research in Developmental Disabilities 31 2010 362 366
37. C.J. McDougle, E.S. Brodkin, S.T. Naylor, D.C. Carlson, D.J. Cohen, and L.H. Price Sertraline in adults with pervasive developmental disorders: A prospective open-label investigation Journal of Clinical Psychopharmacology 18 1998 62 66 (Pubitemid 28045636)
38. C.J. McDougle, E.S. Brodkin, P.P. Yeung, S.T. Naylor, D.J. Cohen, and L.H. Price Risperidone in adults with autism or pervasive developmental disorder Journal of Child Adolescents Psychopharmacology 5 1995 273 282 (Pubitemid 26068363)
39. C.J. McDougle, J.P. Holmes, D.C. Carlson, G.H. Pelton, D.J. Cohen, and L.H. Price A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders Archives of General Psychiatry 58 1998 633 641 (Pubitemid 28340352)
40. C.J. McDougle, S.T. Naylor, D.J. Cohen, F.R. Volume, G.R. Heninger, and L.H. Price A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder Archives of General Psychiatry 53 1996 1001 1008 (Pubitemid 26384669)
41. P. McGill, and J. Poynter High cost residential placements for adults with intellectual disability Journal of Applied Research in Intellectual Disability 25 2012 584 587
42. S.M. Myers The status of psychopharmocolgy for autism spectrum disorders Expert Opinion in Pharmacotherapy 8 11 2007 1579 1603 (Pubitemid 47296548)
43. NICE Autism: Recognition, referral, diagnosis and management of adults on the autism spectrum. Clinical guideline 142 2012 http://guidance.nice.org.uk/ cg142
44. NICE Challenging behaviours and learning disabilities 2014 http://guidance.nice.org.uk/CG/Wave0/654
45. G. O'Brien, and J. Pearson Autism and learning disability Autism 8 2004 125 140 (Pubitemid 38801759)
46. P. Oliver-Africano, S. Dickens, D.Z. Ahmed, N. Bouras, S. Cooray, and S. Deb et al. Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities Journal of Intellectual and Developmental Disabilities 54 2010 17 25
47. M.B. Ospina, J. Krebs Seida, B. Clark, M. Karkhaneh, L. Hartling, and L. Tjosvold et al. Behavioural and developmental interventions for autism spectrum disorder: A clinical systematic review PLoS ONE 3 11 2008 10.1371/journal.pone. 0003755
48. L.C. Polittle, and C.J. McDougle Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders Psychopharmacology 231 6 2014 1023 1036
49. J.J. Ratey, E. Mikkelsen, P. Sorge, H.S. Zuckerman, S. Palokoff, and J. Bemporad et al. Autism: The treatment of aggressive behaviours Journal of Clinical Psychopharmacology 7 1 1987 35 41
50. I.L. Rubin, J.J. Fahs, and J.B. Beasley Delivery of health care for people with "dual diagnosis": From person to the policy Mental Health Aspects of Developmental Disabilities 10 3 2007 1 11
51. P. Sturmey, J.D. Lott, R. Laud, and J.L. Matson Correlates of restraint use in an institutional population: A replication Journal of Intellectual and Developmental Disabilities 49 2005 501 506 (Pubitemid 40932403)
52. W.F. Sullivan, J.M. Berg, E. Bradley, T. Cheetam, R. Denton, and J. Heng et al. Primary care of adults with developmental disabilities: Canadian consensus guidelines Canadian Family Physicians 57 2011 541 553
53. T.C. Theoharides, and S. Asadi Unwanted interactions among psychotropic drugs and other treatments for autism spectrum disorders Journal of Psychopharmacology 32 4 2012 437 440
54. E. Tsakanikos, P. Sturmey, H. Costello, G. Holt, and N. Bouras Referral trends in mental health services for adults with intellectual disability and autism spectrum disorders Autism 11 1 2007 9 17 (Pubitemid 44911682)